Skip to main content
Discover what's not being covered
Get Started
SubscribeLogin
Published • loading... • Updated

AstraZeneca’s stomach cancer drug clears bar for extending overall survival in late-stage study

Summary by WTVB
By Bhanvi Satija MADRID, Oct 25 (Reuters) - AstraZeneca's experimental drug sone-ve helped patients with advanced stomach cancer who had received at least two prior treatments to live longer than analysts had expected, according to late-stage trial ​da...

13 Articles

Il MessaggeroIl Messaggero
Center

Stomach Tumor, the Antibody-Drug Arrives Trojan Horse: Reduces the Risk of Death by 42%

Created the antibody-drug that works as a ?horse of Troy? against tumors. The innovative technology in precision oncology has proven to be...

·Rome, Italy
Read Full Article
WTVBWTVB
Center

AstraZeneca’s stomach cancer drug clears bar for extending overall survival in late-stage study

By Bhanvi Satija MADRID, Oct 25 (Reuters) - AstraZeneca's experimental drug sone-ve helped patients with advanced stomach cancer who had received at least two prior treatments to live longer than analysts had expected, according to late-stage trial ​da...

Read Full Article
La RepúblicaLa República

Astra Drug for Stomach Cancer Doubled Survival Time

According to preliminary analysis, if the experimental drug proves its goodness, it would sell up to US$5 billion.

·Bogota, Colombia
Read Full Article
cancernetwork.comcancernetwork.com

Sonesitatug Vedotin Improves OS in Pretreated CLDN18.2+ Gastroesophageal Cancer

Sone-Ve significantly improved OS vs investigator’s choice in previously treated CLDN18.2-positive gastroesophageal carcinoma in CLARITY-Gastric01.

Read Full Article
時事ドットコム時事ドットコム

Cancers: advanced stomach cancer, new therapy reduces risk of death by 42%  (2) - JIJI PRESSCancers: advanced stomach cancer, new therapy reduces risk of death by 42%  (2)

NEWS JIJI PRESS

Read Full Article
koutipandoras.grkoutipandoras.gr

Stomach Cancer: Hopes From New AstraZeneca Drug - Median Survival Doubled | Pandora's Box

Encouraging results from large clinical trial in advanced disease

·Greece
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Giornale Radio broke the news on Sunday, October 25, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

AstraZeneca icon

AstraZeneca

Cancer icon

Cancer

Italy icon

Italy

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal